AI will revolutionise drug discovery and healthcare: ARM CEO Rene Haas

Share via:


Rene Haas, CEO of ARM Holdings, believes the biggest potential for artificial intelligence lies in healthcare. “Designing a chip versus curing cancer—I’m going to bet that the killer app for AI is in health,” he said, pointing to areas such as drug research, gene studies, genomics, and clinical trials.

Haas noted that AI can significantly accelerate the lengthy clinical trial process and drive innovation in drug discovery, helping combat diseases like cancer and Alzheimer’s.

Since the announcement of ARM’s Stargate AI technology in…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

AI will revolutionise drug discovery and healthcare: ARM CEO Rene Haas


Rene Haas, CEO of ARM Holdings, believes the biggest potential for artificial intelligence lies in healthcare. “Designing a chip versus curing cancer—I’m going to bet that the killer app for AI is in health,” he said, pointing to areas such as drug research, gene studies, genomics, and clinical trials.

Haas noted that AI can significantly accelerate the lengthy clinical trial process and drive innovation in drug discovery, helping combat diseases like cancer and Alzheimer’s.

Since the announcement of ARM’s Stargate AI technology in…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

Canton Token Rises Around 25% after DTCC Outlines Tokenized...

Canton Coin has climbed about 27% over the...

Nvidia agrees to buy chip startup Groq’s assets for...

Chipmaker Nvidia will acquire assets from chip startup...

Got a new Mac? Here are five apps I...

Whether you just got your first Mac or...

Popular